Type 2 diabetes mellitus is a progressive metabolic disorder. Marked hyperglycaemia leads
to serious vascular complications. Hence, addressing this modifiable risk factor is of …

Inhibition of the sodium/glucose co-transporter 2 (SGLT2) is a new therapeutic strategy for
diabetes. It is unclear how proximal loss of sodium (Na+)(and glucose) affects the …

The sodium and glucose co-transporter inhibitors type 2 (SGLT2) comprises a new class of
hypoglycemic drugs to control type 2 diabetes mellitus, in an attempt to add new non …

Individuals with diabetes mellitus (DM) are living longer thanks to an armamentarium of
glucose-lowering agents, nutrition and exercise strategies, and education initiatives …

Nesta dissertação pretende-se identificar e clarificar os principais benefícios dos inibidores
SGTL2 para além do controlo glicémico nomeadamente na diminuição do peso corporal, da …

Background Although periodontal abscess is recommended to be used to guide the
screening for diabetes mellitus (DM), the information on their interactions is still limited. This …

Prevalence of type 2 diabetes has increased significantly. It is inferred that the number of
adults with diabetic nephropathy will also increase. Therefore, diabetic nephropathy will …

Diabetes is one of the major causes of chronic kidney disease (CKD) which could lead to
end-stage renal disease. Angiotensin-II (Ang-II), a major bioactive peptide of renin …

Background: The sodium glucose co-transporter 2 (SGLT2) inhibitors are beneficial in
halting diabetic kidney disease, however complete mechanisms are not elucidated yet …

(Mestrado em Biologia Humana e Experimental)–Instituto de Biologia Roberto Alcântara
Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, 2019. A doença …